← k3vl4r
Log inGet started →

GMED (Globus Medical) Price Forecast

AI-generated price forecast for Globus Medical (GMED) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of August 2026: K3vl4r's AI model currently reads GMED as 2/2 bearish · strong across its horizons (0 of 2 timeframes pointing up), with a last price of 86.96. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status📊 Full AI report· ACCUMULATE

Last price

86.96

AI outlook

2/2 bearish · STRONG

Timeframes up

0 / 2

Share𝕏PostTelegram

GMED forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour~6 weeks out———
Daily~4 months out▼ Down-8.91%—
Weekly~1.9 years out▼ Down-15.94%—

Latest GMED news

From the market-news feed the forecasts are read against.

  • Here is Why Growth Investors Should Buy Globus Medical (GMED) Now · Zacks · Aug 17
  • Natera Supports Kupando Trial to Advance ctDNA Monitoring in Cancer · Zacks · Aug 17
  • Globus Medical (GMED) Stock Sees Modest Fair Value Cut As Analysts Trim Growth Views · Yahoo · Aug 12
  • Is Globus Medical (GMED) A Bargain On Its Zacks Upgrade And Reaffirmed Guidance? · Simply Wall St. · Aug 12
  • NPCE Q2 Earnings Beat Estimates on RNS Growth, '26 Revenue View Up · Zacks · Aug 12

🔒

See the full GMED forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

GMED forecast — frequently asked

Will GMED go up?

K3vl4r's AI model currently reads GMED as 2/2 bearish · STRONG — 0 of 2 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the GMED price prediction for 2026?

K3vl4r's model projects GMED toward $85.12 over the next ~4 months, a -0.1% move from $85.20. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could GMED reach?

Over its longest horizon (~~1.9 years), the model's projected target for GMED is $85.16 (-0.2% vs $85.29). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

WGSVNRXMLTXSTTKPGENEWTXEOLSHYPDCELCRCUSSNDAHALOPCVXTNDM

Will GMED reach…?

Will GMED reach $100.00?Will GMED reach $200.00?Will GMED reach $250.00?Will GMED reach $500.00?

Or see the full GMED price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare GMED

GMED vs WGSGMED vs VNRXGMED vs MLTXGMED vs STTKGMED vs PGENGMED vs EWTX

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.